E-LIB Suche - Ergebnisse für: Andreas Sourlas

1

Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Man..:

Kosmas, Constantine E ; Bousvarou, Maria D ; Sourlas, Andreas...
Clinical Pharmacology: Advances and Applications. 14 (2022) - p. 49-59 , 2022

Link: https://doi.org/10.2147/..

2

Safety and Tolerability of PCSK9 Inhibitors: Current Insigh..:

Kosmas, Constantine E ; Skavdis, Andreas ; Sourlas, Andreas...
Clinical Pharmacology: Advances and Applications. 12 (2020) - p. 191-202 , 2020

Link: https://doi.org/10.2147/..

3

Inclisiran: A New Promising Agent in the Management of Hype..:

Kosmas, Constantine E. ; Muñoz Estrella, Alba ; Sourlas, Andreas...
Diseases. 6 (2018) 3 - p. 63 , 2018

Link: https://doi.org/10.3390/..

4

PCSK9 Targeting in the Management of Hypercholesterolaemia:

Constantine E. Kosmas ; Evangelia J. Papakonstantinou ; Jacqueline Carreño...
https://www.emjreviews.com/cardiology/article/pcsk9-targeting-in-the-management-of-hypercholesterolaemia/. , 2023

Link: https://doi.org/10.33590..

5

New and emerging lipid-modifying drugs to lower LDL cholest..:

Constantine E Kosmas ; Dafni Pantou ; Andreas Sourlas...
https://www.drugsincontext.com/new-and-emerging-lipid-modifying-drugs-to-lower-ldl-cholesterol. , 2021

Link: https://doi.org/10.7573/..

6

Editor's Pick: Lipoprotein(a) and Calcific Aortic Valve Ste..:

Constantine E. Kosmas ; Delia Silverio ; Andreas Sourlas...
https://www.emjreviews.com/cardiology/article/calcific-aortic-valve-stenosis/. , 2019

Link: https://doaj.org/article..

7

Therapeutic management of hyperlipoproteinemia (a):

Constantine E Kosmas ; Andreas Sourlas ; Gordon Mallarkey...
https://www.drugsincontext.com/therapeutic-management-of-hyperlipoproteinemia-(a)/. , 2019

Link: https://doi.org/10.7573/..

8

High-density lipoprotein (HDL) functionality and its releva..:

Constantine E Kosmas ; Ian Martinez ; Andreas Sourlas...
http://www.drugsincontext.com/high-density-lipoprotein-hdl-functionality-and-its-relevance-to-atherosclerotic-cardiovascular-disease. , 2018

Link: https://doi.org/10.7573/..

9

Impact of lipid-lowering therapy on glycemic control and th..:

Constantine E Kosmas ; Delia Silverio ; Andreas Sourlas...
https://www.drugsincontext.com/impact-lipid-lowering-therapy-on-glycemic-control-risk-new-onset-diabetes. , 2018

Link: https://doi.org/10.7573/..

10

Inclisiran: A New Promising Agent in the Management of Hype..:

Constantine E. Kosmas ; Alba Muñoz Estrella ; Andreas Sourlas...
Cardiology. , 2018

Link: https://doi.org/10.3390/..

11

Primary genetic disorders affecting high density lipoprotei..:

Constantine E Kosmas ; Delia Silverio ; Andreas Sourlas...
https://www.drugsincontext.com/primary-genetic-disorders-affecting-high-density-lipoprotein-hdl. , 2018

Link: https://doi.org/10.7573/..

12

Inclisiran: A New Promising Agent in the Management of Hype..:

Constantine E. Kosmas ; Alba Muñoz Estrella ; Andreas Sourlas...
http://www.mdpi.com/2079-9721/6/3/63. , 2018

Link: https://doi.org/10.3390/..

13

Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Man..:

Kosmas, Constantine E ; Bousvarou, Maria D ; Sourlas, Andreas...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300746/. , 2022

Link: http://www.ncbi.nlm.nih...

14

Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Man..:

Kosmas, Constantine E ; Bousvarou, Maria D ; Sourlas, Andreas...
info:eu-repo/semantics/altIdentifier/doi/10.2147/CPAA.S345072. , 2022

Link: https://www.dovepress.co..

15

New and emerging lipid-modifying drugs to lower LDL cholest..:

Kosmas, Constantine E ; Pantou, Dafni ; Sourlas, Andreas...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565402/. , 2021

Link: http://www.ncbi.nlm.nih...